Co-Diagnostics, Inc. (CODX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$622.5K

Net Income/Loss (FY2025)

-$46.9M

Total Assets (FY2025)

$24.7M

Total Equity (FY2025)

$20.6M

Cash Flows from Operating Activities (FY2025)

-$29.1M

Source: Co-Diagnostics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.